Is Tenaya Therapeutics Inc (TNYA) overvalued? · rev $1.3M
Tenaya Therapeutics Inc (TNYA) is a biotechnology company listed on NASDAQ.
This page asks whether Tenaya Therapeutics Inc (TNYA) looks expensive on cached numbers — not a short thesis.
Latest reported TNYA revenue for 2026-06-30 was $1.3M. Net income was -$62.7M. TNYA currently screens at market cap $156.0M.
TNYA currently screens at market cap $156.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TNYA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TNYA stock page for the full model, not this heading.
Not investment advice.